current treatment approaches in et and an insight into the surpass-et trial
Published 1 year ago • 85 plays • Length 1:46Download video MP4
Download video MP3
Similar videos
-
2:21
the current state of the art in all and how novel agents are impacting the field
-
2:03
the current landscape of treatment for bpdcn
-
1:24
conventional approaches for all targeted therapies in allo-hsct
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
8:50
who guideline on clinical management of exposure to lead – voices from clinicians and experts
-
22:09
why therapy can leave you feeling worse
-
2:00:01
the microbiota: a new frontier in cancer
-
2:08
an insight into the current understanding of risk factors for cll
-
1:29
the current landscape of maintenace therapy in aml and areas for future exploration
-
1:27
current diagnostic modalities for the identification of ptld
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
1:03
late effect surveillance following allosct: the publication of new guidelines
-
3:10
novel aml treament approaches
-
9:25
mgus diagnosis: a step-by-step approach
-
2:41
an overview of the latest advances in hematology
-
1:32
factors contributing to the pathogenesis of icaht
-
7:30
updates from juliet: correlative analyses and clinical characteristics associated with efficacy
-
3:04
applying molecular understanding of dlbcl to management strategies
-
0:43
elm-2: qol and orr outcomes of odronextamab treatment for r/r fl
-
0:56
evaluating the suitability of shlh diagnostic criteria in adults
-
6:31
immune-transcriptome signatures: a novel approach to understanding gvhd & gvt